Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care.

Abacavir is a nucleoside reverse transcriptase inhibitor used as part of combination antiretroviral therapy in HIV-1-infected patients. Because this drug can cause a hypersensitivity reaction that is correlated with the presence of the HLA-B*57:01 allotype, screening for the presence of HLA-B*57:01...

詳細記述

書誌詳細

主要な著者:	Ward De Spiegelaere, Jan Philippé, Karen Vervisch, Chris Verhofstede, Eva Malatinkova, Maja Kiselinova, Wim Trypsteen, Pawel Bonczkowski, Dirk Vogelaers, Steven Callens, Jean Ruelle, Kabamba Kabeya, Stephane De Wit, Petra Van Acker, Vicky Van Sandt, Marie-Paule Emonds, Paul Coucke, Erica Sermijn, Linos Vandekerckhove
フォーマット:	Artigo
言語:	Inglês
出版事項:	Public Library of Science (PLoS) 2015-01-01
シリーズ:	PLoS ONE
オンライン･アクセス:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0123525&type=printable
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!